Wound repair composite formulation based on fgf2 variants and uses thereof
By developing an NGF2 mutant with improved thermal stability and extended half-life and combining it with a moisturizing cream, the problems of heat intolerance and unstable activity of natural FGF2 protein were solved, achieving the effects of reducing application frequency and improving the durability of wound repair.
Patent Information
- Application Number
- CN202511558985.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-29
- Publication Date
- 2026-06-05
AI Technical Summary
Natural FGF2 protein is heat-sensitive and has unstable activity, leading to the need for frequent administration or injection. Furthermore, it is difficult to maintain its biological activity at room temperature, which limits its practical application.
An NGF2 mutant was developed using protein engineering technology to improve its thermal stability and room temperature half-life. This mutant was then mixed with a water-based cream to form a compound formulation that prolongs the effective duration of action at the wound site.
It reduces the frequency of application, improves the durability of wound repair, and significantly accelerates skin wound healing, especially for chronic wounds such as diabetic foot ulcers.
Smart Images

Figure CN122140606A_ABST
Abstract
Citation Information
Patent Citations
A fusion protein ngf2 with improved half-life in vivo and its use
CN122145644A